Ossifying fibroma (OF) is a well-defined, encapsulated, slow-growing fibro-osseous lesion that can involve the paranasal sinuses and jaw bones. Unlike fibrous dysplasia, it is a true neoplasm and can be separated from bone (suitable for surgical enucleation). It most commonly occurs in the mandibular premolar-molar region; in paranasal sinuses, the ethmoid sinus is most frequently involved. It is more common in women aged 20-40 years. Juvenile ossifying fibroma (JOF) is an aggressive variant showing rapid growth in children. Sinonasal ossifying fibromas are divided into psammomatoid and trabecular subtypes. On CT, it appears as a well-defined, mixed-density (radiolucent + radiopaque), expansile mass separated from surrounding bone by a thin sclerotic capsule (shell sign) — this feature is the most important distinguishing criterion from fibrous dysplasia.
Age Range
10-40
Peak Age
25
Gender
Equal
Prevalence
Rare
Ossifying fibroma is a true neoplasm originating from periodontal ligament or periosteal mesenchymal cells. Neoplastic fibroblasts produce bone or cementum-like calcified material within fibrous stroma — this mixed composition manifests as mixed density (radiolucent + radiopaque) on CT. The lesion is encapsulated and separated from surrounding bone by a capsule — this is the fundamental difference from fibrous dysplasia and the source of the 'shell sign.' The presence of a capsule enables complete removal of the lesion by surgical enucleation. The maturation process progresses centripetally (from outside to inside): peripheral regions show more calcification (sclerotic capsule) and central regions are less mineralized (radiolucent). Juvenile variants (psammomatoid and trabecular) show more aggressive growth, have higher local recurrence rates, and present in early childhood. Psammoma bodies (concentric lamellar calcifications) are characteristic of the psammomatoid type and are common in the ethmoid sinus.
The pathognomonic CT finding of ossifying fibroma is the thin sclerotic bone capsule surrounding the lesion (shell sign). This 1-3 mm thick smooth, continuous, high-density bone ring completely separates the lesion from surrounding bone and enables surgical enucleation. The shell sign is the most critical distinguishing finding from fibrous dysplasia (no capsule, blending with surrounding bone). If capsule integrity is preserved, benign process is supported; if disrupted, aggressive behavior or malignant transformation is considered.
On CT, ossifying fibroma appears as a well-defined, expansile, mixed-density mass. Radiolucent (fibrous tissue — 20-40 HU) and radiopaque (calcified material — 200-800 HU) areas coexist. The radiolucent/radiopaque ratio varies depending on maturation degree: predominantly radiolucent in early stage, predominantly radiopaque in advanced stage. The lesion is separated from surrounding bone by a thin sclerotic capsule (shell sign) — this capsule is a 1-3 mm thick smooth sclerotic bone ring. Preservation of capsule continuity indicates benign process; capsule disruption suggests aggressive variant or malignant transformation. In paranasal sinuses, the ethmoid sinus is most commonly involved and the lesion may expand into adjacent sinuses and orbit.
Report Sentence
A well-defined, expansile fibro-osseous lesion with mixed density surrounded by thin sclerotic capsule (shell sign) is observed in the ethmoid sinus; the appearance is consistent with ossifying fibroma.
The pathognomonic finding of ossifying fibroma on bone window CT is the 'shell sign' — a thin, smooth sclerotic bone capsule surrounding the lesion. This capsule consists of 1-3 mm thick high-density (>800 HU) compact bone and completely separates the lesion from surrounding bone. If capsule continuity is preserved throughout, benign process is confirmed. If the capsule is focally disrupted or violated, aggressive variant (juvenile OF) or secondary infection should be considered. The shell sign is the most critical finding for differentiation from fibrous dysplasia (no capsule, blending with surrounding bone) and malignant tumors (capsule destruction, periosteal reaction).
Report Sentence
An intact thin sclerotic capsule (shell sign) is observed surrounding the lesion, separating it from surrounding bone by a distinct border; this finding supports the diagnosis of ossifying fibroma.
On MRI, ossifying fibroma shows heterogeneous signal on T2-weighted sequences. The fibrous component shows intermediate-to-low T2 signal (collagen fibers) while cystic and edematous areas show hyperintense T2 signal. Mineralized areas appear as signal void. This heterogeneous signal pattern reflects the mixed histologic composition of the lesion. The capsule shows low signal on T2 (compact bone — signal void). Surrounding bone marrow changes (edema, reactive changes) may appear hyperintense on T2. Orbital or intracranial extension of the lesion is best evaluated on T2 and contrast-enhanced T1 sequences.
Report Sentence
The lesion shows heterogeneous signal on T2-weighted sequences with intermediate-to-low signal fibrous component, hyperintense cystic areas, and signal void mineralized areas coexisting.
On T1-weighted sequences, ossifying fibroma shows low-to-intermediate signal — signal varies depending on the predominance of fibrous stroma and mineralized components. Normal bone marrow fat signal is absent because the medullary cavity is filled by the lesion. On post-contrast T1 fat-sat sequences, the fibrous component shows moderate-to-prominent enhancement. Mineralized areas do not enhance (remain signal void). Cystic areas may show peripheral ring enhancement. The capsule does not enhance (avascular compact bone). The enhancement pattern provides information about the vascularity and fibrous/mineralized ratio of the lesion.
Report Sentence
The lesion shows low-to-intermediate signal on T1-weighted sequences; moderate enhancement of the fibrous component is observed on post-contrast sequences while mineralized areas show no enhancement.
In ossifying fibroma, maturation progresses centripetally (from outside to inside), creating a characteristic density gradient on CT. Peripheral regions are at more advanced maturation and contain more calcification — the sclerotic capsule is a result of this advanced maturation. Central regions are less mineralized and more radiolucent. This centripetal pattern distinguishes from fibrous dysplasia's homogeneous ground-glass density and osteoma's homogeneous high density. Immature (early) lesions are predominantly radiolucent and may be confused with simple bone cyst or ameloblastoma. Mature (advanced) lesions are predominantly radiopaque and may be confused with osteoma or cementoblastoma.
Report Sentence
A centripetal maturation pattern is observed in the lesion, with peripheral regions more calcified (sclerotic capsule) and central regions more radiolucent.
Ultrasonography provides evaluation capability for superficially located ossifying fibromas (mandible, anterior maxillary face). On US, ossifying fibroma appears as a mixed-echogenicity mass: fibrous component is hypoechoic, mineralized areas are hyperechoic with posterior acoustic shadowing. The capsule may be visible as a thin hyperechoic ring. The heterogeneous echo pattern in internal structure reflects the mixed density on CT. Moderate vascularity may be observed in the fibrous component on Doppler examination. The primary role of US is first-line evaluation and biopsy guidance for mandibular and maxillary lesions — the role of US is limited for paranasal sinus-located lesions.
Report Sentence
A mixed-echogenicity, well-defined lesion with hyperechoic capsule is observed in the bone, with hypoechoic fibrous areas and hyperechoic mineralized areas coexisting.
Criteria
Most common type. Mandibular premolar-molar region in women aged 20-40. Slow growth, well-defined, encapsulated. Histology: lamellar bone and cementum within fibrous stroma. CT: mixed density with shell sign. Complete removal by surgical enucleation, low recurrence rate (5-10%).
Distinct Features
Most common in mandible, slow growth, low aggressiveness. Prominent shell sign. Density varies with maturation. Cure by surgical enucleation. Recurrence rare. Radiologic diagnosis usually sufficient, biopsy may be needed but not mandatory.
Criteria
Aggressive variant. In children and young adults (5-25 years). Common in paranasal sinuses, especially ethmoid and frontal sinuses. Histology: psammoma bodies (concentric lamellar calcifications). Rapid growth, high recurrence rate (30-56%). Orbital invasion common.
Distinct Features
Common in paranasal sinuses, rapid growth, orbital extension. Fine calcification foci on CT (psammoma bodies). Capsule may be intact but locally aggressive growth. Wide surgical excision required (different from simple enucleation). Long-term follow-up mandatory due to high recurrence rate.
Criteria
Aggressive variant. Most common in maxilla in children (2-12 years). Histology: trabecular bone formation, cellular fibrous stroma. Rapid growth, can be expansile and locally destructive. High recurrence rate (30-58%).
Distinct Features
Common in maxilla, very young age (2-12), rapid expansile growth. More radiolucent center on CT (less mature). Capsule may be disrupted (aggressive). Wide surgical excision + long follow-up. Trabecular bone pattern predominant unlike psammomatoid type.
Distinguishing Feature
Fibrous dysplasia has no capsule and the lesion blends with surrounding bone (imperceptible transition) — ossifying fibroma shows distinct border with shell sign. Fibrous dysplasia shows homogeneous ground-glass density, ossifying fibroma shows mixed density. Fibrous dysplasia usually does not require biopsy, ossifying fibroma is treated surgically.
Distinguishing Feature
Osteoma shows homogeneous very high bone density (>1000 HU compact type) — different from ossifying fibroma's mixed density. Osteoma is an intraluminal mass while ossifying fibroma grows expansively from within bone. Osteoma shows no capsule, ossifying fibroma shows shell sign. MRI is signal void on all sequences in osteoma, heterogeneous signal in ossifying fibroma.
Distinguishing Feature
SCC shows aggressive bone destruction and irregular-bordered soft tissue mass — ossifying fibroma is an encapsulated, expansile lesion with preserved bone. SCC shows heterogeneous enhancement and necrosis, ossifying fibroma has more homogeneous internal structure. Cervical lymphadenopathy is common in SCC, absent in ossifying fibroma.
Distinguishing Feature
Olfactory neuroblastoma originates from the olfactory cleft and shows intracranial extension (dumbbell morphology). Ossifying fibroma originates from bone and is encapsulated. Olfactory neuroblastoma shows homogeneous enhancement and peripheral cyst, ossifying fibroma shows mixed density and shell sign. Olfactory neuroblastoma is a soft tissue mass, ossifying fibroma is a fibro-osseous lesion.
Urgency
routineManagement
surgicalBiopsy
NeededFollow-up
Conventional OF: annual CT for 3-5 years after surgery to monitor for recurrence. Juvenile variants: CT every 6 months for 5 years then annually for 5 more years due to high recurrence rates (30-58%). Clinical follow-up lifelong for juvenile variants.Ossifying fibroma is a benign neoplasm requiring surgical treatment. Conventional type can be completely removed by surgical enucleation — it separates easily from bone due to capsule and recurrence rate is low (5-10%). Juvenile variants (JPOF, JTOF) are more aggressive, require wide surgical excision, and have high recurrence rates (30-58%). Biopsy/histopathology is usually required for definitive diagnosis — differentiation from fibrous dysplasia and other fibro-osseous lesions is clinically important because treatment approach differs. Radiotherapy is contraindicated (malignant transformation risk). Multidisciplinary approach (radiology + surgeon + ophthalmology) is required for lesions showing orbital or intracranial extension.
Ossifying fibroma is a benign lesion that can be surgically enucleated. The juvenile aggressive form (juvenile ossifying fibroma) grows faster and may behave locally aggressively. Complete surgical excision is curative; recurrence rate is low after complete excision.